Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma

Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphomas (ALK+ ALCL) occur predominantly in children and young adults. Their treatment, based on aggressive chemotherapy, is not optimal since ALCL patients can still expect a 30% 2-year relapse rate. Tumor relapses are very aggressive and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitou, Géraldine, Frentzel, Julie, Desquesnes, Aurore, Le Gonidec, Sophie, AlSaati, Talal, Beau, Isabelle, Lamant, Laurence, Meggetto, Fabienne, Espinos, Estelle, Codogno, Patrice, Brousset, Pierre, Giuriato, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745787/
https://www.ncbi.nlm.nih.gov/pubmed/26338968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745787/
https://www.ncbi.nlm.nih.gov/pubmed/26338968

Ejemplares similares